J.P. Morgan keeps AUD 3.10 target for Sigma Healthcare stock
Published on 10/24/2026 at 19:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSJ.P. Morgan keeps AUD 3.10 target
- J.P. Morgan maintained a Buy rating and AUD 3.10 target on October 23, 2026.
- Quarterly revenue reached AUD 5.33 billion and net profit AUD 329.36 million for the quarter ended June 30.
- Sigma Healthcare stock was trading at EUR 1.73 at Lang & Schwarz on October 24, 2026 at 1:04 p.m. CEST.
Sigma Healthcare (AU000000SIG5) received a maintained Buy rating and an AUD 3.10 target from J.P. Morgan on October 23, 2026, according to Markets Insider. Against the ASX price of AUD 2.74 on October 23, 2026, the target stood 13.14 percent above the share price. Sigma stock was trading at EUR 1.73 at Lang & Schwarz on October 24, 2026 at 1:04 p.m. CEST.
Quarterly figures add scale
The latest reported quarter ended June 30, 2026, with revenue of AUD 5.33 billion and net profit of AUD 329.36 million. Markets Insider said the comparable figures for the prior year were AUD 4.04 billion in revenue and AUD 219.99 million in net profit. The comparison puts the latest quarter's revenue AUD 1.29 billion above the prior-year figure and net profit AUD 109.37 million higher.
Valuation remains the counterweight
Sigma Healthcare's ASX price was AUD 2.74 on October 23, 2026, with a market capitalization of AUD 31.5 billion and a price-to-earnings ratio of 44.48. The 52-week range was AUD 2.47 to AUD 3.20, placing the last ASX price AUD 0.46 above the low and AUD 0.46 below the high. The Australian quotation therefore sits between two clearly defined reference points, while the J.P. Morgan target is above the latest exchange price.
Pharmacy distribution drives the profile
Sigma Healthcare describes itself as a full-line pharmaceutical wholesaler and retail pharmacy franchisor. Its website identifies Amcal, Chemist Warehouse and Discount Drug Stores among the network's brands. The company also lists contract logistics as part of its operating platform, giving the earnings figures a distribution and retail context.
Euro quote for German investors
The euro quotation offers a separate view of the Australian healthcare distributor for investors in Germany. The ASX price and the Lang & Schwarz quotation use different currencies and venues, so they are not combined into one performance figure.
The further course of trading is shown by the continuously updated real-time quote of Sigma Healthcare stock.
Sigma Healthcare market data
- Company: Sigma Healthcare Limited
- ISIN: AU000000SIG5
- Ticker: SIG
- Primary exchange: ASX
- Price Lang & Schwarz (as of October 24, 2026, 1:04 p.m. CEST): EUR 1.73
- Market capitalization: AUD 31.5 billion (as of October 23, 2026)
- 52-week range: AUD 2.47-3.20 (as of October 23, 2026)
- Sector / Industry: Healthcare / Medical distribution
Market context: Market report S&P ASX 200.
